Open access
1,263
Views
0
CrossRef citations to date
0
Altmetric
Oncology
A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan
Toru Kiguchia Dokkyo Medical University Saitama Medical Center, Saitama, Japan
, Masaya Sakuraib Astellas Pharma Inc., Tokyo, JapanCorrespondence[email protected]
, Yusuke Tanakab Astellas Pharma Inc., Tokyo, Japan
, Kazuyuki Kuramotob Astellas Pharma Inc., Tokyo, Japan
, Yuki Kadoc IQVIA Solutions Japan K.K., Tokyo, Japan
, Sono Sawadac IQVIA Solutions Japan K.K., Tokyo, Japan
& Takeshi Mitomib Astellas Pharma Inc., Tokyo, Japan
show all
Pages 1513-1522
|
Received 30 Jun 2023, Accepted 12 Oct 2023, Published online: 02 Nov 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.